Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.

@article{Rallis2005SuccessfulTO,
  title={Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.},
  author={Efstathios Rallis and A Nasiopoulou and Constantinos Kouskoukis and A V Roussaki-Schulze and E Koumantaki and Anthony Karpouzis and Antonios Arvanitis},
  journal={Drugs under experimental and clinical research},
  year={2005},
  volume={31 4},
  pages={
          141-5
        }
}
Tacrolimus is an immunomodulatory agent that inhibits the activation and maturation of T-cells and blocks transcriptional activation of several cytokine genes. It also interferes with the function of Langerhans cells, basophil cells and mast cells. Recent studies have demonstrated the efficacy of topical tacrolimus in inflammatory skin disorders. Our objective was to assess the efficacy of topical treatment with tacrolimus ointment 0.1% in patients with psoriasis on the anogenital region and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Genital Psoriasis: Impact on Quality of Life and Treatment Options

  • American Journal of Clinical Dermatology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND